- Report
- March 2023
- 255 Pages
Global
From €2484EUR$2,500USD£2,065GBP
From €1490EUR$1,500USD£1,239GBP
- Report
- March 2023
- 80 Pages
South Korea
From €1490EUR$1,500USD£1,239GBP
- Report
- March 2023
- 80 Pages
Saudi Arabia
From €1490EUR$1,500USD£1,239GBP
- Report
- March 2023
- 80 Pages
Russia
From €1490EUR$1,500USD£1,239GBP
- Report
- March 2023
- 80 Pages
India
From €1490EUR$1,500USD£1,239GBP
- Report
- March 2023
- 80 Pages
Germany
From €1490EUR$1,500USD£1,239GBP
- Report
- March 2023
- 80 Pages
France
From €1490EUR$1,500USD£1,239GBP
- Report
- March 2023
- 80 Pages
China
From €1490EUR$1,500USD£1,239GBP
- Report
- March 2023
- 80 Pages
Brazil
From €1490EUR$1,500USD£1,239GBP
- Report
- August 2022
- 40 Pages
Saudi Arabia
From €1490EUR$1,500USD£1,239GBP
- Report
- August 2022
- 40 Pages
India
From €1490EUR$1,500USD£1,239GBP
- Report
- August 2022
- 100 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- April 2022
- 80 Pages
Africa
From €1987EUR$2,000USD£1,652GBP
- Report
- April 2022
- 40 Pages
Brazil
From €1490EUR$1,500USD£1,239GBP
- Report
- April 2022
- 40 Pages
China
From €1490EUR$1,500USD£1,239GBP
- Report
- April 2022
- 40 Pages
France
From €1490EUR$1,500USD£1,239GBP
- Report
- April 2022
- 40 Pages
Germany
From €1490EUR$1,500USD£1,239GBP
- Report
- April 2022
- 40 Pages
India
From €1490EUR$1,500USD£1,239GBP
- Report
- April 2022
- 40 Pages
Ireland
From €1490EUR$1,500USD£1,239GBP
The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more